☆ 4.5 Review

The usual Interstitial pneumonia pattern in autoimmune rheumatic diseases

BMC PULMONARY MEDICINE (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Biochemistry & Molecular Biology

Lung Damage in Rheumatoid Arthritis-A Retrospective Study

Georgiana Dinache et al.

Summary: This study aimed to assess the clinical characteristics of rheumatoid arthritis (RA) patients with interstitial lung disease (ILD) and determine their association with X-ray and high-resolution computed tomography (HR-CT) findings. Results showed that male RA patients had a higher prevalence of nodules, combined fibrosis and nodules, and combined bronchiectasis and nodules on chest X-rays, while rheumatoid factor (RF)-positive patients had a higher prevalence of fibrosis and anti-cyclic citrullinated peptide antibodies (ACPA)-positive patients had a higher prevalence of bronchiectasis. In terms of HR-CT findings, patients on methotrexate treatment had a higher prevalence of nodules, combined fibrosis and nodules, combination of emphysema and nodules, and combination of fibrosis, emphysema, and nodules. ILD was found to develop within approximately 5 years from RA diagnosis, and it was more prevalent in men with RA, among patients with positive RA serology (RF and/or ACPA), and RA patients on methotrexate.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

添加到收藏夹

Article Critical Care Medicine

Usual interstitial pneumonia as a stand-alone diagnostic entity: the case for a paradigm shift?

Moises Selman et al.

Summary: Usual interstitial pneumonia (UIP) has a distinctive appearance that has been considered the hallmark of idiopathic pulmonary fibrosis (IPF), but it is also seen in other fibrotic interstitial lung diseases. This article advocates for the designation of UIP as a single diagnostic entity, including its primary form and secondary processes in various disorders. The current separation between primary and secondary UIP does not reflect the similarities between them in terms of appearance, behavior, pathogenesis, and efficacy of treatment.

LANCET RESPIRATORY MEDICINE (2023)

添加到收藏夹

Article Medicine, General & Internal

Evolution of Rheumatoid-Arthritis-Associated Interstitial Lung Disease in Patients Treated with JAK Inhibitors: A Retrospective Exploratory Study

Vincenzo Venerito et al.

Summary: The aim of this multicenter retrospective study was to investigate the effectiveness and safety of JAK-inhibitors (JAKi) in patients with rheumatoid arthritis (RA) and interstitial lung disease (ILD). The study suggests that JAKi therapy might be a safe therapeutic option for patients with RA-ILD in a short-term follow-up.

JOURNAL OF CLINICAL MEDICINE (2023)

添加到收藏夹

Article Critical Care Medicine

Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study

Joshua J. Solomon et al.

Summary: This study evaluated the safety, tolerability, and efficacy of pirfenidone for the treatment of patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD). The results showed that although it did not meet the primary endpoint, pirfenidone slowed the rate of decline in lung function in patients with RA-ILD.

LANCET RESPIRATORY MEDICINE (2023)

添加到收藏夹

Article Pharmacology & Pharmacy

Current and Future Treatment Landscape for Idiopathic Pulmonary Fibrosis

Francesco Bonella et al.

Summary: Idiopathic pulmonary fibrosis (IPF) is a disease with poor survival and complex pathogenesis. While current drugs can slow disease progression, there is a need for new treatment strategies. Several new drugs are currently in clinical development, but our understanding of IPF is still limited.

DRUGS (2023)

添加到收藏夹

Article Critical Care Medicine

Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline

Ganesh Raghu et al.

Summary: This article provides updates on the guidelines for idiopathic pulmonary fibrosis (IPF) and addresses the progression of pulmonary fibrosis in patients with interstitial lung diseases (ILDs) other than IPF. The recommendations are based on consensus and systematic reviews, aiming to provide evidence-based guidance for clinicians.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Canonical and noncanonical regulatory roles for JAK2 in the pathogenesis of rheumatoid arthritis-associated interstitial lung disease and idiopathic pulmonary fibrosis

Shaohua Wang et al.

Summary: This study uses RNA sequencing of lung biopsies from patients with RA-ILD and IPF to identify shared and distinct disease-causing pathways. The results suggest that JAK2 plays a crucial role in the development of fibrotic lung diseases.

FASEB JOURNAL (2022)

添加到收藏夹

Article Pathology

The histologic diagnosis of usual interstitial pneumonia of idiopathic pulmonary fibrosis. Where we are and where we need to go

Maxwell L. Smith

Summary: This manuscript reviews the evolution of histologic diagnosis of UIP, its relationship with IPF, and methods for distinguishing fibrotic lung disease mimics of UIP/IPF.

MODERN PATHOLOGY (2022)

添加到收藏夹

Article Rheumatology

Nintedanib in Patients With Autoimmune Disease-Related Progressive Fibrosing Interstitial Lung Diseases: Subgroup Analysis of the INBUILD Trial

Eric L. Matteson et al.

Summary: In fibrosing autoimmune disease-related interstitial lung diseases (ILDs) with a progressive phenotype, nintedanib demonstrated efficacy in slowing the rate of decline in forced vital capacity (FVC), with manageable adverse events.

ARTHRITIS & RHEUMATOLOGY (2022)

添加到收藏夹

Article Rheumatology

A Risk Score to Detect Subclinical Rheumatoid Arthritis-Associated Interstitial Lung Disease

Pierre-Antoine Juge et al.

Summary: This study developed and validated a risk score to identify high-risk patients of subclinical RA-ILD, with findings supporting an important contribution of MUC5B rs35705950 to the risk of subclinical RA-ILD.

ARTHRITIS & RHEUMATOLOGY (2022)

添加到收藏夹

Review Respiratory System

Current best clinical practices for monitoring of interstitial lung disease

Elisabeth Bendstrup et al.

Summary: Interstitial lung diseases (ILDs) are a heterogeneous group of inflammatory and/or fibrotic conditions with variable outcome and often a dismal prognosis. Monitoring of ILDs is a multimodality process and includes measurement of pulmonary function and exercise capacity, symptom registration and quality of life (QoL), imaging, comorbidities and/or involvement of other organs. Future strategies for monitoring ILDs may include telemedicine, artificial intelligence, and new imaging tools.

EXPERT REVIEW OF RESPIRATORY MEDICINE (2022)

添加到收藏夹

Review Multidisciplinary Sciences

Pharmacological treatment for connective tissue disease-associated interstitial lung involvement: Protocol for an overview of systematic reviews and meta-analyses

Fotini Karassa et al.

Summary: This overview aims to summarize existing evidence on the effectiveness and harm of pharmacological therapies for adults with CTD-ILD. A literature search will be conducted to identify systematic reviews with or without meta-analysis that examine pharmacological treatment for CTD-ILD. The primary outcomes will be changes in lung function measures and adverse events.

PLOS ONE (2022)

添加到收藏夹

Review Respiratory System

Management of progressive pulmonary fibrosis associated with connective tissue disease

Maria Molina-Molina et al.

Summary: Fibrotic interstitial lung disease (ILD) is a common and severe complication of connective tissue disease (CTD). The subtype and degree of fibrosis in ILD associated with CTD usually determine the prognosis and treatment strategy. Some CTD-ILD patients may develop progressive pulmonary fibrosis (PPF), leading to worsened lung function and high mortality. PPF requires a multidisciplinary diagnostic and therapeutic approach to improve patient outcomes.

EXPERT REVIEW OF RESPIRATORY MEDICINE (2022)

添加到收藏夹

Review Respiratory System

Immunomodulatory treatment of interstitial lung disease

Laura van den Bosch et al.

Summary: Interstitial lung diseases (ILDs) other than idiopathic pulmonary fibrosis (IPF) have more immunomodulatory treatment options due to their inflammatory component. However, there is a lack of guidance on managing this group of diseases. Immunosuppression is the main therapy for ILDs, with different levels of evidence for each specific ILD. Classification of ILDs is crucial for treatment decisions.

THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE (2022)

添加到收藏夹

Article Rheumatology

Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database

Anna-Maria Hoffmann-Vold et al.

Summary: This study utilized data from the European Scleroderma Trials And Research (EUSTAR) database to analyze the disease course, progression patterns, and predictive factors for progressive interstitial lung disease (ILD) in patients with systemic sclerosis-associated ILD (SSc-ILD). The results showed that male sex, higher modified Rodnan skin score, and reflux/dysphagia symptoms were the strongest predictive factors for forced vital capacity (FVC) decline over a 5-year period in SSc-ILD patients.

ANNALS OF THE RHEUMATIC DISEASES (2021)

添加到收藏夹

Review Medicine, Research & Experimental

Estimation of the Prevalence of Progressive Fibrosing Interstitial Lung Diseases: Systematic Literature Review and Data from a Physician Survey

Amy Olson et al.

Summary: Through a systematic review of ILD prevalence, it was found that 13-40% of ILDs may progress to a fibrosing phenotype, with overall prevalence estimates of 2.2-20.0 per 100,000 in Europe and 28.0 per 100,000 in the USA for progressive fibrosing ILDs. Prevalence estimates for individual progressive fibrosing ILDs varied up to 16.7 per 100,000 people. These conditions represent a significant portion of chronic respiratory disorders and have high unmet needs.

ADVANCES IN THERAPY (2021)

添加到收藏夹

Review Respiratory System

Two sides of the same coin? A review of the similarities and differences between idiopathic pulmonary fibrosis and rheumatoid arthritis-associated interstitial lung disease

Scott Matson et al.

Summary: Although RA-ILD and IPF are distinct diseases, they share several clinical, radiographic, and genetic features, sparking interest in their relationship. Understanding the links between these diseases could fundamentally change strategies for the diagnosis, screening, and treatment of ILD.

EUROPEAN RESPIRATORY JOURNAL (2021)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Volume-related structures predict UIP pathology in those with a non-IPF pattern on CT

Jonathan H. Chung et al.

Summary: The study indicates that VRS can differentiate patients with UIP histological features from non-IPF diagnosis in CT images, showing predictive value. The sensitivity and specificity of VRS in predicting pathological UIP are comparable to standard qualitative CT assessment.

EUROPEAN RADIOLOGY (2021)

添加到收藏夹

Review Immunology

Rheumatoid arthritis related interstitial lung disease

Andreina Manfredi et al.

Summary: Rheumatoid arthritis-related interstitial lung disease is a common extra-articular manifestation that significantly impacts patients' quality of life and overall prognosis, necessitating early diagnosis and treatment. High-resolution computed tomography is the gold standard for ILD diagnosis, but determining the correct therapeutic strategy remains challenging due to the high variability of clinical presentation and disease progression. A multidisciplinary approach involving rheumatologists, pulmonologists, and radiologists is currently recommended to define optimal therapy and follow-up strategies.

EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2021)

添加到收藏夹

Article Medicine, General & Internal

Interstitial Lung Disease in Connective Tissue Diseases: Survival Patterns in a Population-Based Cohort

Charlotte Hyldgaard et al.

Summary: The study found that the frequency of ILD and pulmonary hypertension varied among different connective tissue disease subtypes. The five-year survival rate was lowest in SSc-ILD and highest in MCTD-ILD, myositis-ILD, SLE-ILD, and Sjogren-associated ILD. Overall, the survival rate was lower in CTD-ILD compared to CTD alone across different age groups.

JOURNAL OF CLINICAL MEDICINE (2021)

添加到收藏夹

Review Rheumatology

Systematic review of the impact of drugs on diffuse interstitial lung disease associated with rheumatoid arthritis

Carmen Carrasco Cubero et al.

Summary: The available evidence suggests that methotrexate (MTX) and leflunomide (LEF) do not worsen the prognosis of patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD). Anti-TNF treatments may have worse outcomes in incidence, progression, and mortality of ILD compared to MTX and LEF, while rituximab (RTX) and abatacept (ABA) appear to have better results.

REUMATOLOGIA CLINICA (2021)

添加到收藏夹

Article Critical Care Medicine

Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial

Juergen Behr et al.

Summary: This multicentre, double-blind, randomised, placebo-controlled trial aimed to evaluate the efficacy and safety of pirfenidone in patients with progressive fibrotic interstitial lung diseases. Results after 48 weeks showed a significantly lower decline in FVC % predicted in the pirfenidone group compared to placebo, suggesting that adding pirfenidone to existing treatment might attenuate disease progression in these patients.

LANCET RESPIRATORY MEDICINE (2021)

添加到收藏夹

Meeting Abstract Rheumatology

DEVELOPPING A SCORE TO PREDICT PRECLINICAL INTERSTITIAL LUNG DISEASE IN PATIENTS WITH RHEUMATOID ARTHRITIS - A CROSS-SECTIONAL STUDY FROM THE ESPOIR COHORT

P. A. Juge et al.

ANNALS OF THE RHEUMATIC DISEASES (2021)

添加到收藏夹

Review Immunology

Efficacy and safety of abatacept in interstitial lung disease of rheumatoid arthritis: A systematic literature review

Esther F. Vicente-Rabaneda et al.

Summary: Current evidence suggests that ABA may be a plausible alternative to treat RA patients with ILD. It would be highly desirable to develop prospective randomized controlled studies to confirm these findings.

AUTOIMMUNITY REVIEWS (2021)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Computed Tomography Findings Suggestive of Connective Tissue Disease in the Setting of Usual Interstitial Pneumonia

Jonathan H. Chung et al.

Summary: In patients with UIP pattern, the presence of SES or AULS is more common in CTD-ILD than IPF. The presence of SES is associated with improved survival, especially in IPF patients. AULS is linked to pulmonary functional abnormalities.

JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY (2021)

添加到收藏夹

Review Medicine, General & Internal

Disease pathology in fibrotic interstitial lung disease: is it all about usual interstitial pneumonia?

Elisabetta A. Renzoni et al.

Summary: Interstitial pneumonias encompass a diverse group of diseases with distinct histopathological features, often defined by their cause. There is a growing focus on the progressive fibrosing phenotype of interstitial lung disease, particularly due to the failure of conventional therapies in some patients and the widespread use of antifibrotic therapies. Apart from the typical usual interstitial pneumonia, other histological entities are also associated with progressive fibrosis, and techniques like immunohistochemistry and single-cell RNA sequencing are providing pathogenetic insights that could impact the pathological classification.

LANCET (2021)

添加到收藏夹

Review Respiratory System

Factors associated with mortality in rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis

Meihua Qiu et al.

Summary: Through this systematic review and meta-analysis, older age, male sex, smoking history, higher CPI, lower DLCO% predicted, lower FVC% predicted, UIP pattern on HRCT, emphysema presence, and acute exacerbation of ILD were found to be associated with increased risk of mortality in RA-ILD patients. However, rheumatoid factor (RF) positive status was not associated with mortality.

RESPIRATORY RESEARCH (2021)

添加到收藏夹

Review Rheumatology

Natural history and screening of interstitia lung disease in systemic autoimmune rheumatic disorders

Panagiotis Panagopoulos et al.

Summary: ILD is a common manifestation of SARDs, presenting with different patterns and variable clinical courses, significantly impacting the clinical outcomes of patients with SARDS.

THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE (2021)

添加到收藏夹

Review Rheumatology

Interstitial lung disease pathology in systemic sclerosis

Kristine E. Konopka et al.

Summary: Interstitial lung disease is a common manifestation of systemic sclerosis, with fibrotic nonspecific interstitial pneumonia being the most common form followed by usual interstitial pneumonia. Lung biopsy may not be necessary for confirming the presence of interstitial lung disease in the right clinical setting, with surgical lung biopsies often reserved for atypical presentations. This review discusses histological findings in SSc-ILD and other changes sometimes seen in lung biopsies from systemic sclerosis patients.

THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE (2021)

添加到收藏夹

Article Critical Care Medicine

Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial

Toby M. Maher et al.

LANCET RESPIRATORY MEDICINE (2020)

添加到收藏夹

Article Medicine, General & Internal

Tocilizumab therapy in rheumatoid arthritis with interstitial lung disease: a multicentre retrospective study

Andreina Manfredi et al.

INTERNAL MEDICINE JOURNAL (2020)

添加到收藏夹

Review Medicine, General & Internal

Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease: Lights and Shadows

Giulia Cassone et al.

JOURNAL OF CLINICAL MEDICINE (2020)

添加到收藏夹

Review Respiratory System

Recent advances in rheumatoid arthritis-associated interstitial lung disease

Pierre-Antoine Juge et al.

CURRENT OPINION IN PULMONARY MEDICINE (2020)

添加到收藏夹

Article Medicine, General & Internal

Combination Therapy with Nintedanib and Sarilumab for the Management of Rheumatoid Arthritis Related Interstitial Lung Disease

Caterina Vacchi et al.

CASE REPORTS IN MEDICINE (2020)

添加到收藏夹

Article Medicine, General & Internal

Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease

Oliver Distler et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

添加到收藏夹

Review Critical Care Medicine

Multidisciplinary Evaluation in Patients with Lung Disease Associated with Connective Tissue Disease

Athol Wells et al.

SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2019)

添加到收藏夹

Article Respiratory System

Pulmonary Pathology in Rheumatic Disease

Andrea Arrossi

CLINICS IN CHEST MEDICINE (2019)

添加到收藏夹

Article Medicine, General & Internal

Nintedanib in Progressive Fibrosing Interstitial Lung Diseases

K. R. Flaherty et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

添加到收藏夹

Article Respiratory System

Poor lung ultrasound score in shock patients admitted to the ICU is associated with worse outcome

Wanhong Yin et al.

BMC PULMONARY MEDICINE (2019)

添加到收藏夹

Review Respiratory System

Interstitial lung disease associated with systemic sclerosis (SSc-ILD)

Vincent Cottin et al.

RESPIRATORY RESEARCH (2019)

添加到收藏夹

Article Respiratory System

Rheumatoid Arthritis-Associated Interstitial Lung Disease: Clinical Characteristics and Predictors of Mortality

Charlotte Hyldgaard et al.

RESPIRATION (2019)

添加到收藏夹

Article Respiratory System

What's in a name? That which we call IPF, by any other name would act the same

Athol U. Wells et al.

EUROPEAN RESPIRATORY JOURNAL (2018)

添加到收藏夹

Review Medicine, General & Internal

Idiopathic Pulmonary Fibrosis

David J. Lederer et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

添加到收藏夹

Review Rheumatology

The Lung in Rheumatoid Arthritis Focus on Interstitial Lung Disease

Paolo Spagnolo et al.

ARTHRITIS & RHEUMATOLOGY (2018)

添加到收藏夹

Review Critical Care Medicine

Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper

David A. Lynch et al.

LANCET RESPIRATORY MEDICINE (2018)

添加到收藏夹

Article Critical Care Medicine

Diagnosis of Idiopathic Pulmonary Fibrosis An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline

Ganesh Raghu et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)

添加到收藏夹

Article Medicine, General & Internal

MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease

P. -A. Juge et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

添加到收藏夹

Review Respiratory System

The epidemiology of idiopathic pulmonary fibrosis and interstitial lung diseases at risk of a progressive-fibrosing phenotype

Amy L. Olson et al.

EUROPEAN RESPIRATORY REVIEW (2018)

添加到收藏夹

Review Respiratory System

Current best practice in rehabilitation in interstitial lung disease

Atsuhito Nakazawa et al.

THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE (2017)

添加到收藏夹

Article Respiratory System

Shared genetic predisposition in rheumatoid arthritis-interstitial lung disease and familial pulmonary fibrosis

Pierre-Antoine Juge et al.

EUROPEAN RESPIRATORY JOURNAL (2017)

添加到收藏夹

Review Medicine, General & Internal

Idiopathic pulmonary fibrosis

Luca Richeldi et al.

LANCET (2017)

添加到收藏夹

Article Rheumatology

Short-Term Pulmonary Function Trends Are Predictive of Mortality in Interstitial Lung Disease Associated With Systemic Sclerosis

Nicole S. Goh et al.

ARTHRITIS & RHEUMATOLOGY (2017)

添加到收藏夹

Article Rheumatology

A population-based cohort study of rheumatoid arthritis-associated interstitial lung disease: comorbidity and mortality

Charlotte Hyldgaard et al.

ANNALS OF THE RHEUMATIC DISEASES (2017)

添加到收藏夹

Article Rheumatology

Prevalence and characterization of non-sicca onset primary Sjogren syndrome with interstitial lung involvement

Andreina Manfredi et al.

CLINICAL RHEUMATOLOGY (2017)

添加到收藏夹

Article Critical Care Medicine

In-Hospital Mortality after Surgical Lung Biopsy for Interstitial Lung Disease in the United States

John P. Hutchinson et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Six-minute walk test in systemic sclerosis: A systematic review and meta-analysis

Els Vandecasteele et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)

添加到收藏夹

Article Rheumatology

An Open-label, Phase II Study of the Safety and Tolerability of Pirfenidone in Patients with Scleroderma-associated Interstitial Lung Disease: the LOTUSS Trial

Dinesh Khanna et al.

JOURNAL OF RHEUMATOLOGY (2016)

添加到收藏夹

Review Medicine, General & Internal

Management of interstitial lung disease associated with connective tissue disease

Stephen C. Mathai et al.

BMJ-BRITISH MEDICAL JOURNAL (2016)

添加到收藏夹

Review Medicine, General & Internal

Management of interstitial lung disease associated with connective tissue disease

Stephen C. Mathai et al.

BMJ-BRITISH MEDICAL JOURNAL (2016)

添加到收藏夹

Review Pharmacology & Pharmacy

Pirfenidone: A Review of Its Use in Idiopathic Pulmonary Fibrosis

Esther S. Kim et al.

DRUGS (2015)

添加到收藏夹

Review Respiratory System

Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis

Lutz Wollin et al.

EUROPEAN RESPIRATORY JOURNAL (2015)

添加到收藏夹

Article Rheumatology

Changes in forced vital capacity over time in systemic sclerosis: application of group-based trajectory modelling

Ada Man et al.

RHEUMATOLOGY (2015)

添加到收藏夹

Review Medicine, General & Internal

The diagnosis and management of interstitial lung diseases

Adam Wallis et al.

BMJ-BRITISH MEDICAL JOURNAL (2015)

添加到收藏夹

Review Medicine, General & Internal

The diagnosis and management of interstitial lung diseases

Adam Wallis et al.

BMJ-BRITISH MEDICAL JOURNAL (2015)

添加到收藏夹

Article Multidisciplinary Sciences

Pirfenidone for Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis

Carlos Aravena et al.

PLOS ONE (2015)

添加到收藏夹

Article Respiratory System

6-minute walk distance is an independent predictor of mortality in patients with idiopathic pulmonary fibrosis

Roland M. du Bois et al.

EUROPEAN RESPIRATORY JOURNAL (2014)

添加到收藏夹

Review Rheumatology

Interstitial lung disease in connective tissue disease-mechanisms and management

Athol U. Wells et al.

NATURE REVIEWS RHEUMATOLOGY (2014)

添加到收藏夹

Article Critical Care Medicine

An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias

William D. Travis et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)

添加到收藏夹

Article Rheumatology

Mycophenolate Mofetil Improves Lung Function in Connective Tissue Disease-associated Interstitial Lung Disease

Aryeh Fischer et al.

JOURNAL OF RHEUMATOLOGY (2013)

添加到收藏夹

Article Respiratory System

The big clinical trials in idiopathic pulmonary fibrosis

Fabrizio Luppi et al.

CURRENT OPINION IN PULMONARY MEDICINE (2012)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Rheumatoid lung disease: Prognostic analysis of 54 biopsy-proven cases

Yutaro Nakamura et al.

RESPIRATORY MEDICINE (2012)

添加到收藏夹

Article Rheumatology

Interstitial lung disease related to rheumatoid arthritis: Evolution after treatment

Jorge Rojas-Serrano et al.

REUMATOLOGIA CLINICA (2012)

添加到收藏夹

Article Critical Care Medicine

An Official ATS/ERSARS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management

Ganesh Raghu et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)

添加到收藏夹

Article Rheumatology

Combined Pulmonary Fibrosis and Emphysema Syndrome in Connective Tissue Disease

Vincent Cottin et al.

ARTHRITIS AND RHEUMATISM (2011)

添加到收藏夹

Article Respiratory System

Lung diseases directly associated with rheumatoid arthritis and their relationship to outcome

Y. Tsuchiya et al.

EUROPEAN RESPIRATORY JOURNAL (2011)

添加到收藏夹

Article Medicine, General & Internal

A Common MUC5B Promoter Polymorphism and Pulmonary Fibrosis

Max A. Seibold et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

添加到收藏夹

Article Respiratory System

Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease

E. J. Kim et al.

EUROPEAN RESPIRATORY JOURNAL (2010)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Walking distance on 6-MWT is a prognostic factor in idiopathic pulmonary fibrosis

Antonella Caminati et al.

RESPIRATORY MEDICINE (2009)

添加到收藏夹

Article Critical Care Medicine

Prognosis of fibrotic interstitial pneumonia - Idiopathic versus collagen vascular disease-related subtypes

Joo Hun Park et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)

添加到收藏夹

Article Rheumatology

The heart and cardiovascular manifestations in rheumatoid arthritis

A. E. Voskuyl

RHEUMATOLOGY (2006)

添加到收藏夹

Article Critical Care Medicine

Idiopathic pulmonary fibrosis - Prognostic value of changes in physiology and six-minute-walk test

Kevin R. Flaherty et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)

添加到收藏夹

Review Rheumatology

Rheumatoid pleural effusion

Alexandra Balbir-Gurman et al.

SEMINARS IN ARTHRITIS AND RHEUMATISM (2006)

添加到收藏夹

Article Critical Care Medicine

Pulmonary manifestations of primary Sjogren's syndrome

I Ito et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)

添加到收藏夹

Article Critical Care Medicine

Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome

D Bouros et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2002)

添加到收藏夹

Article Critical Care Medicine

Polymyositis-dermatomyositis-associated interstitial lung disease

WW Douglas et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)

添加到收藏夹

Article Rheumatology

Ten year follow up of pulmonary function in patients with primary Sjogren's syndrome

BKS Davidson et al.

ANNALS OF THE RHEUMATIC DISEASES (2000)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.